Adult Acute Myeloid Leukemia

The number of leukemia patients and survivors is growing. Acute Myeloid Leukemia (AML) is one of the most common types of adult leukemia, with at least 13,000 individuals diagnosed each year in the U.S. The incidence increases with age, with 16.0 per 100,000 individuals age ≥ 65 years compared to 1.7 per 100,000 individuals age <65. The average age at diagnosis in the U.S. is 66 years old. Approximately 60 to 70% of adult patients (aged 18-65 years) will achieve complete remission (CR), with 50-70% of first CR patients relapsing within 3 years. Approximately 22.6% of adult AML patients survive to five years . Though there are relapses beyond this time period , most 5-year survivors are considered cured.

• Share this page
• 
• 
• 
• 
• 
• 

Last date updated on April, 2024